Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Novel aspects of the activation of NADPH oxidase in neutrophils of rheumatic patients on biological therapy.

Jančinová V, Drábiková K, Killinger Z, Pažoureková S, Nosáľ R, Payer J.

Int Immunopharmacol. 2019 Apr;69:368-372. doi: 10.1016/j.intimp.2019.02.015. Epub 2019 Feb 15.

PMID:
30776645
2.

Weber-Christian disease: a case report.

Brázdilová K, Čierny D, Hrubišková K, Plank L, Killinger Z, Payer J.

Vnitr Lek. Fall 2018;64(10):961-965.

PMID:
30590944
3.

Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study.

Kužma M, Vaňuga P, Ságová I, Pávai D, Jackuliak P, Killinger Z, Binkley NC, Winzenrieth R, Genant HK, Payer J.

Eur J Endocrinol. 2019 Mar 1;180(3):201-211. doi: 10.1530/EJE-18-0881.

PMID:
30566903
4.

Biologic treatment in comparison to methotrexate has positive effect on trabecular bone score in rheumatoid arthritis patients: 1-year follow-up.

Killinger Z, Gajdarova L, Kuzma M, Krajcovicova A, Brazdilova K, Jackuliak P, Payer J.

Acta Clin Belg. 2019 Apr;74(2):121-125. doi: 10.1080/17843286.2018.1512189. Epub 2018 Aug 23.

PMID:
30136633
5.

Increased intracellular and extracellular oxidant production in phagocytes of rheumatic patients treated with biological therapy - whole blood quantification.

JančInová V, Nosáľ R, Payer J, Killinger Z.

Interdiscip Toxicol. 2017 Oct;10(2):52-55. doi: 10.1515/intox-2017-0008.

6.

Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults.

Ku CR, Brue T, Schilbach K, Ignatenko S, Magony S, Chung YS, Kim BJ, Hur KY, Kang HC, Kim JH, Kim MS, Kowalska A, Bolanowski M, Ruchala M, Damjanovic S, Payer J, Choi YJ, Heo SJ, Kim TK, Heo M, Lee J, Lee EJ.

Eur J Endocrinol. 2018 Sep;179(3):169-179. doi: 10.1530/EJE-18-0185. Epub 2018 Jul 4.

PMID:
29973375
7.

High Serum Fractalkine is Associated with Lower Trabecular Bone Score in Premenopausal Women with Graves' Disease.

Kužma M, Vaňuga P, Binkley N, Ságová I, Pávai D, Blažíček P, Kužmová Z, Jackuliak P, Vaňuga A, Killinger Z, Payer J.

Horm Metab Res. 2018 Aug;50(8):609-614. doi: 10.1055/a-0633-2814. Epub 2018 Jun 28.

PMID:
29954010
8.

[Cyclic Cushings syndrome: a case study and overview].

Kollerová J, Malina J, Šteňo A, Povinec P, Payer J.

Vnitr Lek. Spring 2018;64(4):450-456. Review. Czech.

PMID:
29791181
9.

[Issues related to secondary osteoporosis associated with growth hormone deficiency in adulthood].

Kužma M, Jackuliak P, Killinger Z, Vaňuga P, Payer J.

Vnitr Lek. Fall 2017;63(10):658-661. Review. Czech.

PMID:
29127748
10.

[Antidiabetic drugs and their effect on bone].

Jackuliak P, Kužma M, Payer J.

Vnitr Lek. Fall 2017;63(9):609-616. Review. Czech.

PMID:
29120659
11.

[Bone quality in patients with acromegaly].

Kužma M, Ságová I, Pavai D, Jackuliak P, Killinger Z, Vaňuga P, Payer J.

Vnitr Lek. Fall 2017;63(9):589-592. Czech.

PMID:
29120655
12.

[Thyroid screening in pregnancy - guideline in practice].

Páleníková P, Kalafutová I, Horníková Z, Payer J.

Vnitr Lek. Fall 2017;63(9):555-560. Czech.

PMID:
29120650
13.

Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control study.

Krajcovicova A, Kuzma M, Hlavaty T, Hans D, Koller T, Jackuliak P, Leskova Z, Sturdik I, Killinger Z, Payer J.

Eur J Gastroenterol Hepatol. 2018 Jan;30(1):101-106. doi: 10.1097/MEG.0000000000000997.

PMID:
29064848
14.

Less strict intervention thresholds for the FRAX and TBS-adjusted FRAX predict clinical fractures in osteopenic postmenopausal women with no prior fractures.

Kužma M, Hans D, Koller T, Némethová E, Jackuliak P, Killinger Z, Resch H, Payer J.

J Bone Miner Metab. 2018 Sep;36(5):580-588. doi: 10.1007/s00774-017-0864-1. Epub 2017 Sep 7.

PMID:
28884422
15.

["Snags" connected with establishing the vitamin D].

Vaňuga A, Huba P, Ságová I, Blažíček P, Melegová J, Payer J, Vaňuga P.

Vnitr Lek. Summer 2017;63(6):403-408. Czech.

PMID:
28840736
16.

Corrigendum to "Osteoporosis, Fractures, and Diabetes".

Jackuliak P, Payer J.

Int J Endocrinol. 2017;2017:2846080. doi: 10.1155/2017/2846080. Epub 2017 May 30.

17.

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study.

Koller T, Galambosova M, Filakovska S, Kubincova M, Hlavaty T, Toth J, Krajcovicova A, Payer J.

World J Gastroenterol. 2017 Jun 14;23(22):4102-4111. doi: 10.3748/wjg.v23.i22.4102.

18.

[Von Hippel-Lindau syndrome - two sides of the same coin].

Páleníková P, Adamcová M, Šturdík I, Ftáčniková B, Copáková L, Payer J.

Vnitr Lek. Winter 2016;62(12):1004-1008. Review. Czech.

PMID:
28139130
19.

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.

Strasburger CJ, Vanuga P, Payer J, Pfeifer M, Popovic V, Bajnok L, Góth M, Olšovská V, Trejbalová L, Vadasz J, Fima E, Koren R, Amitzi L, Bidlingmaier M, Hershkovitz O, Hart G, Biller BMK.

Eur J Endocrinol. 2017 Mar;176(3):283-294. doi: 10.1530/EJE-16-0748. Epub 2016 Dec 8.

20.

[Hemosuccus pancreaticus - rare complication of chronic pancreatitis].

Šturdík I, Kužma M, Kužmová Z, Koller T, Javorka V, Hlavatý T, Payer J.

Vnitr Lek. Fall 2016;62(10):833-836. Czech.

PMID:
27900870
21.

Cross-sectional area of the median nerve is increased in primary autoimmune hypothyroidism and decreases upon treatment with thyroxine.

Holováčová D, Kužma M, Killinger Z, Payer J.

Eur J Endocrinol. 2016 Oct;175(4):265-71. doi: 10.1530/EJE-16-0397. Epub 2016 Jul 14.

PMID:
27418060
22.

[Hepatic transit times and liver elasticity compared with meld in predicting a 1 year adverse clinical outcome of a clinically diagnosed cirrhosis].

Koller T, Piešťanská Z, Hlavatý T, Holomáň J, Glasa J, Payer J.

Vnitr Lek. Spring 2016;62(5):351-9. Czech.

PMID:
27319227
23.

[DRESS syndrome].

Adamcová M, Šturdík I, Koller T, Payer J.

Vnitr Lek. 2016 Apr;62(4):334-7. Czech.

PMID:
27250614
24.

[Fecal microbiota transplantation].

Šturdík I, Hlavatý T, Payer J.

Vnitr Lek. 2016 Feb;62(2):147-51. Review. Czech.

PMID:
27172442
25.

[Hormonal changes in inflammatory bowel disease].

Kollerová J, Koller T, Hlavatý T, Payer J.

Vnitr Lek. 2015 Dec;61(12 Suppl 5):5S35-9. Slovak.

PMID:
27124970
26.

TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.

Kužma M, Binkley N, Bednárová A, Killinger Z, Vaňuga P, Payer J.

Endocr Pract. 2016 Aug;22(8):951-8. doi: 10.4158/EP151183.OR. Epub 2016 Apr 4.

PMID:
27042750
27.

[Hormonal changes in inflammatory bowel disease].

Kollerová J, Koller T, Hlavatý T, Payer J.

Vnitr Lek. 2015;61 Suppl 5:35-9. Czech.

PMID:
26800471
28.

Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.

Kovářová M, Koller T, Štvrtinová V, Payer J.

Endokrynol Pol. 2015;66(6):474-9. doi: 10.5603/EP.2015.0058.

29.

Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein.

Balaž M, Ukropcova B, Kurdiova T, Vlcek M, Surova M, Krumpolec P, Vanuga P, Gašperíková D, Klimeš I, Payer J, Wolfrum C, Ukropec J.

Adipocyte. 2014 Dec 17;4(2):113-22. doi: 10.4161/21623945.2014.973772. eCollection 2015 Apr-Jun.

30.

Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much?

Hlavaty T, Krajcovicova A, Payer J.

J Crohns Colitis. 2015 Feb;9(2):198-209. Review.

PMID:
26046136
31.

[The most recent aspects of diagnosis and therapy of hyponatraemia].

Šturdík I, Adamcová M, Payer J.

Vnitr Lek. 2015 Mar;61(3):209-18. Review. Czech.

PMID:
25873117
32.

Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.

Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, Payer J.

World J Gastroenterol. 2014 Nov 14;20(42):15787-96. doi: 10.3748/wjg.v20.i42.15787.

33.

Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients.

Koller T, Kollerova J, Huorka M, Meciarova I, Payer J.

Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1108-15. doi: 10.1097/MEG.0000000000000182.

PMID:
25188444
34.

Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients.

Krajcovicova A, Hlavaty T, Killinger Z, Miznerova E, Toth J, Letkovsky J, Nevidanska M, Cierny D, Koller T, Zelinkova Z, Huorka M, Payer J.

J Crohns Colitis. 2014 Dec;8(12):1693-701. doi: 10.1016/j.crohns.2014.08.004. Epub 2014 Aug 27.

PMID:
25175812
35.

Adipokine zinc-α2-glycoprotein regulated by growth hormone and linked to insulin sensitivity.

Balaz M, Ukropcova B, Kurdiova T, Gajdosechova L, Vlcek M, Janakova Z, Fedeles J, Pura M, Gasperikova D, Smith SR, Tkacova R, Klimes I, Payer J, Wolfrum C, Ukropec J.

Obesity (Silver Spring). 2015 Feb;23(2):322-8. doi: 10.1002/oby.20856. Epub 2014 Aug 7.

36.

Osteoporosis, fractures, and diabetes.

Jackuliak P, Payer J.

Int J Endocrinol. 2014;2014:820615. doi: 10.1155/2014/820615. Epub 2014 Jun 23. Review. Erratum in: Int J Endocrinol. 2017;2017:2846080.

37.

The effect of growth hormone replacement therapy on the morphological and functional changes in the left ventricle in patients with adult-onset growth hormone deficiency.

Dlesk A, Kamenský G, Lazúrová I, Kužma M, Payer J.

Wien Klin Wochenschr. 2014 Aug;126(15-16):480-4. doi: 10.1007/s00508-014-0536-2. Epub 2014 Jul 1.

PMID:
24981406
38.

[Extraadrenal paraganglioma].

Teliarová Z, Kollerová J, Jackuliak P, Breza J, Payer J.

Vnitr Lek. 2014 May-Jun;60(5-6):514-9. Czech.

PMID:
24974757
39.

Therapeutic adherence to osteoporosis treatment.

Tomková S, Telepková D, Vanuga P, Killinger Z, Sulková I, Celec P, Payer J.

Int J Clin Pharmacol Ther. 2014 Aug;52(8):663-8. doi: 10.5414/CP202072.

PMID:
24887334
40.

Hyponatraemia is an independent predictor of in-hospital mortality.

Sturdik I, Adamcova M, Kollerova J, Koller T, Zelinkova Z, Payer J.

Eur J Intern Med. 2014 Apr;25(4):379-82. doi: 10.1016/j.ejim.2014.02.002. Epub 2014 Feb 26. Erratum in: Eur J Intern Med. 2014 Oct;25(8):784.

PMID:
24582329
41.

Treatment of Pathological Bone Fractures in a Patient with McCune-Albright Syndrome.

Kollerova J, Koller T, Zelinkova Z, Kostalova L, Payer J.

Case Rep Endocrinol. 2013;2013:589872. doi: 10.1155/2013/589872. Epub 2013 Nov 28.

42.

Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 2-3 December 2011.

Payer J, Bilezikian JP, Holzer G, Lakatos P, Lesnyak O, Lorenc R, Zendeli A, Resch H.

Arch Osteoporos. 2013;8:123. doi: 10.1007/s11657-013-0123-6. Epub 2013 Feb 12.

PMID:
23400563
43.

Long-term efficacy of infliximab for treating Takayasu arteritis.

Killinger Z, Cierny D, Jackuliak P, Zelinkova Z, Rovensky J, Payer J.

Isr Med Assoc J. 2012 Dec;14(12):771-3. No abstract available.

44.

Osteoarticular changes in acromegaly.

Killinger Z, Kužma M, Sterančáková L, Payer J.

Int J Endocrinol. 2012;2012:839282. Epub 2012 Sep 12.

45.

Hashimoto encephalopathy: a rare intricate syndrome.

Payer J, Petrovic T, Lisy L, Langer P.

Int J Endocrinol Metab. 2012 Spring;10(2):506-14. doi: 10.5812/ijem.4174. Epub 2012 Apr 20.

46.

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J.

Scand J Gastroenterol. 2012 Feb;47(2):197-203. doi: 10.3109/00365521.2011.643481. Epub 2011 Dec 19.

PMID:
22182015
47.

[Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].

Kuzma M, Payer J.

Cas Lek Cesk. 2010;149(5):211-6. Review. Slovak.

PMID:
20629339
48.

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.

Payer J, Brazdilova K, Jackuliak P.

Drug Healthc Patient Saf. 2010;2:49-59. Epub 2010 May 20.

49.

Severe hemolytic uremia syndrome and antiphospholipid antibodies following bowel infection in the absence of major vascular occlusions: an example of MAPS?

Sedlak T, Payer J, Horvathova D, Killinger Z, Hatalova A, Rovensky J, Asherson RA.

Isr Med Assoc J. 2008 Dec;10(12):896-8. No abstract available.

50.

Whipple's disease-generalized stage.

Jackuliak P, Koller T, Baqi L, Plank L, Lasabova Z, Minarik G, Payer J.

Dig Dis Sci. 2008 Dec;53(12):3250-8. doi: 10.1007/s10620-008-0288-9. Epub 2008 Jun 4.

PMID:
18523887

Supplemental Content

Loading ...
Support Center